1. Home
  2. ORGS
  3. ORGS News

Latest Orgenesis Inc. (ORGS) News on July 27, 2024

Italian energy company targets Britain for fleet of 20 mini-nukes
ORGS

The Telegraph

2 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
ORGS

Simply Wall St.

2 months ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
ORGS

Simply Wall St.

2 months ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
ORGS

Simply Wall St.

2 months ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
ORGS

Motley Fool

2 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?
ORGS

Simply Wall St.

2 months ago

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)
ORGS

Simply Wall St.

2 months ago

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Seoul resumes loudspeaker propaganda against North
ORGS

AFP

2 months ago

Seoul resumes loudspeaker propaganda against North

Orgenesis Provides Business Update for the First Quarter of 2024
ORGS

GlobeNewswire

2 months ago

Orgenesis Provides Business Update for the First Quarter of 2024

Orgenesis Provides Year End Business Update
ORGS

GlobeNewswire

3 months ago

Orgenesis Provides Year End Business Update

Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
ORGS

GlobeNewswire

4 months ago

Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility

Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference
ORGS

GlobeNewswire

4 months ago

Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference

Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes
ORGS

GlobeNewswire

4 months ago

Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes

Orgenesis Inc. Announces $2.3 Million Private Placement
ORGS

GlobeNewswire

5 months ago

Orgenesis Inc. Announces $2.3 Million Private Placement

Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
ORGS

GlobeNewswire

5 months ago

Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing

EXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic
ORGS

Benzinga

6 months ago

EXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic

Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic
ORGS

GlobeNewswire

6 months ago

Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic

ORGS

GlobeNewswire

6 months ago

Diamond Equity Research Releases Update Note on YS Biopharma Co., Ltd. (NASDAQ: YS)

D-Wave Joins Forces with Deloitte Canada to Advance Quantum Adoption
ORGS

Business Wire

6 months ago

D-Wave Joins Forces with Deloitte Canada to Advance Quantum Adoption

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
ORGS

PR Newswire

6 months ago

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024

Future FinTech CEO Denies SEC’s Manipulative-Trading Allegations
ORGS

The Wall Street Journal

6 months ago

Future FinTech CEO Denies SEC’s Manipulative-Trading Allegations

Paramount Gold Nevada Closes $15 Million Financing With Sprott Streaming
ORGS

GlobeNewswire

7 months ago

Paramount Gold Nevada Closes $15 Million Financing With Sprott Streaming

Blue Ridge Bankshares, Inc. Announces the Signing of Definitive Purchase Agreements for $150 Million in a Private Placement
ORGS

PR Newswire

7 months ago

Blue Ridge Bankshares, Inc. Announces the Signing of Definitive Purchase Agreements for $150 Million in a Private Placement

Kineta to Host KOL Event to Review New Data from VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors on December 5, 2023
ORGS

GlobeNewswire

8 months ago

Kineta to Host KOL Event to Review New Data from VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors on December 5, 2023

Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
ORGS

Business Wire

8 months ago

Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Analysts Expect Orgenesis Inc. (NASDAQ:ORGS) To Breakeven Soon
ORGS

Simply Wall St.

8 months ago

Analysts Expect Orgenesis Inc. (NASDAQ:ORGS) To Breakeven Soon

Vintage Wine Estates Names Farzana Shubarna as Vice President of Operations
ORGS

Business Wire

8 months ago

Vintage Wine Estates Names Farzana Shubarna as Vice President of Operations

Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
ORGS

GlobeNewswire

8 months ago

Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer

Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
ORGS

Newsfile

8 months ago

Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Duos Technologies Group Reports Third Quarter 2023 Results
ORGS

GlobeNewswire

8 months ago

Duos Technologies Group Reports Third Quarter 2023 Results

Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM
ORGS

GlobeNewswire

8 months ago

Orgenesis Ranked No. 171st Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500 TM

Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
ORGS

GlobeNewswire

8 months ago

Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives

Orgenesis Provides Business Update for the Third Quarter of 2023
ORGS

GlobeNewswire

8 months ago

Orgenesis Provides Business Update for the Third Quarter of 2023

Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering
ORGS

GlobeNewswire

9 months ago

Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering

Katapult Delivers 10% Year-Over-Year Revenue Growth In Third Quarter 2023
ORGS

GlobeNewswire

9 months ago

Katapult Delivers 10% Year-Over-Year Revenue Growth In Third Quarter 2023

ORGS

Associated Press Finance

9 months ago

Minerva Neurosciences: Q3 Earnings Snapshot

Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
ORGS

GlobeNewswire

9 months ago

Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates

Share on Social Networks: